Executive Director, Head of EpidemiologyDaiichi Sankyo, Inc.Wyncote, Pennsylvania, United States
Disclosure information not submitted.
5D-05 - Assessing the appropriateness of using EB05 for signal detection in a company’s spontaneous pharmacovigilance database with low case volume in a therapeutic area
Tuesday, August 26, 20259:30 AM - 9:45 AM ET